These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18317983)

  • 1. [Treatment of sialorrhea in patients under long-term ventilation].
    Winterholler M
    Pneumologie; 2008 Mar; 62 Suppl 1():S39-42. PubMed ID: 18317983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialorrhea: a management challenge.
    Hockstein NG; Samadi DS; Gendron K; Handler SD
    Am Fam Physician; 2004 Jun; 69(11):2628-34. PubMed ID: 15202698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current approach to hyper-sialorrhea].
    Defossez W
    Rev Belge Med Dent (1984); 2006; 61(3):173-9. PubMed ID: 17408138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drooling of saliva: a review of the etiology and management options.
    Meningaud JP; Pitak-Arnnop P; Chikhani L; Bertrand JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jan; 101(1):48-57. PubMed ID: 16360607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
    Fuster Torres MA; Berini Aytés L; Gay Escoda C
    Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ; Dahl JP; Rose AS
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A in the treatment of sialorrhea.
    Benson J; Daugherty KK
    Ann Pharmacother; 2007 Jan; 41(1):79-85. PubMed ID: 17190848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drooling.
    Lal D; Hotaling AJ
    Curr Opin Otolaryngol Head Neck Surg; 2006 Dec; 14(6):381-6. PubMed ID: 17099344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
    Khan A; Pawar G
    W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF; Hassouna HNH; Yildirim YS; Dogan R; Ozturan O
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):104-112. PubMed ID: 30371109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
    Su CS; Lan MY; Liu JS; Chang CC; Lai SL; Wu HS; Chen SS; Chang YY
    Acta Neurol Taiwan; 2006 Sep; 15(3):170-6. PubMed ID: 16995596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of drooling with botulinum toxin A in neurologically disabled children.
    Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
    Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.
    Boyce HW; Bakheet MR
    J Clin Gastroenterol; 2005 Feb; 39(2):89-97. PubMed ID: 15681902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based approach to the child who drools saliva.
    Little SA; Kubba H; Hussain SS
    Clin Otolaryngol; 2009 Jun; 34(3):236-9. PubMed ID: 19531173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva control issues in the neurologically challenged. A 30 year experience in team management.
    Crysdale WS; McCann C; Roske L; Joseph M; Semenuk D; Chait P
    Int J Pediatr Otorhinolaryngol; 2006 Mar; 70(3):519-27. PubMed ID: 16146657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical prevalence of drooling in infant cerebral palsy.
    Morales Chávez MC; Nualart Grollmus ZC; Silvestre-Donat FJ
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E22-6. PubMed ID: 18167475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.